About this episode

The episode revisits the topic of SSRIs with an update after 100 episodes.

One hundred episodes later, let’s take it back to one of our very first, the Selective Serotonin Reuptake Inhibitors - with a much-needed update. Thank you to our guests, fans, and listeners. References: https://pmc.ncbi.nlm.nih.gov/articles/PMC4428540/ https://pubmed.ncbi.nlm.nih.gov/10333979⁠ ⁠https://pmc.ncbi.nlm.nih.gov/articles/PMC3663330/⁠

People in this episode

Hosts: Dr. Tanner Hewitt, Dr. Larry Wang, Dr. Bradley Miller

Topics covered

• SSRIs
• mental health
• psychiatry
• medication update
• podcast milestone

Keywords

• SSRIs
• Selective Serotonin Reuptake Inhibitors
• psychiatry
• mental health
• medication

Mentioned in this episode

Books & works: Selective Serotonin Reuptake Inhibitors

More episodes of PsychRounds: The Psychiatry Podcast

• Amantadine (Symmetrel) · April 8, 2026 · 17 min
• VMAT2 Inhibitors: Valbenazine (Ingrezza) and Deutetrabenazine (Austedo) · March 21, 2026 · 17 min
• A DSM Conversation with Dr. Allen Frances · February 25, 2026 · 56 min
• Topiramate (Topamax) · January 28, 2026 · 15 min
• What Makes Something a Psychiatric Illness? Featuring Dr. Mark Ruffalo, MSW, DPsa · January 14, 2026 · 55 min
• Lorazepam (Ativan) · December 31, 2025 · 14 min

Explore listener stats, chart rankings, contacts and more on the PsychRounds: The Psychiatry Podcast podcast page.